Allergan

Johnson & Johnson, AbbVie, Teva and Endo to face pharma's first opioid trial since 2019
Johnson & Johnson, AbbVie, Teva and Endo to face pharma's first opioid trial since 2019
Fierce Pharma
JNJ
AbbVie
Allergan
Teva Pharmaceutical
Endo
opioids
opioid crisis
Flag link:
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
Endpoints
AbbVie
Women's Health
Allergan
Humira
M&A
Flag link:
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Eli Lilly
Amgen
migraines
Allergan
Novartis
Biohaven
Teva Pharmaceutical
Flag link:
AbbVie dumps unwanted Sosei neuro pact from Allergan's past
AbbVie dumps unwanted Sosei neuro pact from Allergan's past
Fierce Biotech
AbbVie
Allergan
M&A
Sosei
Flag link:
Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox
Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox
Biopharma Reporter
Aji Biopharma
ReVance
drug manufacturing
aesthetics
daxiabotulinumtoxinA
Botox
Allergan
AbbVie
Flag link:
AbbVie's Botox wins reprieve as agency bars Evolus' Jeaveau for alleged trade-secrets theft
AbbVie's Botox wins reprieve as agency bars Evolus' Jeaveau for alleged trade-secrets theft
Fierce Pharma
AbbVie
Allergan
Botox
ITC
Evolus
Jeuveau
Flag link:
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
Endpoints
AbbVie
Allergan
Humira
Rinvoq
Flag link:
Unmet Need in Dry Eye Disease Market Leaves Room for Other Drugmakers to Step In
Unmet Need in Dry Eye Disease Market Leaves Room for Other Drugmakers to Step In
BioSpace
dry eye disease
Novartis
Allergan
Sun Pharma
Bausch
Kala Pharmaceuticals
Flag link:
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Endpoints
Allergan
AbbVie
presbyopia
clinical trials
AGN-190584
Flag link:
AbbVie’s Allergan Aesthetics brand gets a facelift
AbbVie’s Allergan Aesthetics brand gets a facelift
Fierce Pharma
AbbVie
Allergan
aesthetics
branding
Flag link:
Its sale to Allergan was called off at the last minute. One year later, a biotech co-founded by Henri Termeer finds a new buyer
Its sale to Allergan was called off at the last minute. One year later, a biotech co-founded by Henri Termeer finds a new buyer
Endpoints
Lysosomal Therapeutics
Allergan
R&D
M&A
Henri Termeer
Bial
Flag link:
Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO
Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO
NASDAQ
Vesper Healthcare Acquisition
Brent Saunders
Allergan
SPAC
IPOs
Flag link:
AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial
AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial
Xconomy
AbbVie
Urogen
overactive bladder
Allergan
Botox
Flag link:
AbbVie cuts Editas CRISPR pact it inherited from Allergan
AbbVie cuts Editas CRISPR pact it inherited from Allergan
Fierce Biotech
Editas Medicine
Allergan
AbbVie
gene editing
CRISPR
Flag link:
AbbVie draws first blood in trade secrets war between Allergan's Botox and Evolus
AbbVie draws first blood in trade secrets war between Allergan's Botox and Evolus
Fierce Pharma
AbbVie
Allergan
Evolus
Botox
Jeuveau
Daewoong Pharmaceuticals
Flag link:
FDA rejects AbbVie's eye drug, citing safety concerns
FDA rejects AbbVie's eye drug, citing safety concerns
BioPharma Dive
Allergan
AbbVie
FDA
abicipar
Molecular Partners
wet age-related macular degeneration
Flag link:
Allergan ex-CEO Saunders takes board seat at BridgeBio
Allergan ex-CEO Saunders takes board seat at BridgeBio
Fierce Biotech
Brent Saunders
Pharma CEOs
Allergan
BridgeBio
Flag link:
Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact
Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact
Fierce Biotech
Assembly Biosciences
microbiome
Allergan
AbbVie
M&A
Flag link:
Abbvie-Allergan complete, but critics continue to raise anti-competitive concerns
Abbvie-Allergan complete, but critics continue to raise anti-competitive concerns
Endpoints
AbbVie
Allergan
M&A
FTC
Flag link:
Breast Implant Makers Land in Hot Water with FDA
Breast Implant Makers Land in Hot Water with FDA
Medical Devices and Diagnostics Industry
FDA
breast implants
devices
Allergan
Ideal Implant
Flag link:

Pages